CMS certification 100038
Memorial Regional Hospital
3501 Johnson St, Hollywood, FL 33021
Memorial Regional Hospital has a CMS overall rating of 3 out of 5 stars. 72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 4. Emergency patients spend a median of 2 h 37 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 3,584 completed surveys, 17% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | FL | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 727 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 37 min | 2 h 36 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 13 visits sampled | 3 h 23 min | 3 h 40 min | 4 h 17 min |
| Left before being seen Lower is better · 189,906 patients | 1% | 1% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 188 patients | 73% | 73% | 65% |
How Memorial Regional Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Memorial Regional HospitalThis hospital | 3/5 | 72% | 2 h 37 min | 3 better 4 worse |
| Memorial Hospital PembrokeSame county · Pembroke Pines | 4/5 | 76% | 2 h 10 min | 1 better 1 worse |
| Memorial Hospital WestSame county · Pembroke Pines | 3/5 | 76% | 3 h 20 min | 3 better 3 worse |
| Memorial Hospital MiramarSame county · Miramar | 5/5 | 78% | 2 h 50 min | 1 better 1 worse |
| HCA Florida Northwest HospitalSame county · Margate | 2/5 | 56% | 2 h 29 min | 2 better 3 worse |
| Broward Health NorthSame county · Deerfield Beach | 3/5 | 65% | 3 h 7 min | 2 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Hollywood.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,672 cases | Too few cases | 3.6% | 3.9% |
| Heart attack 127 cases | Too few cases | 10.6% | 11.9% |
| Heart failure 384 cases | Too few cases | 7.8% | 11.1% |
| Pneumonia 323 cases | Too few cases | 14.6% | 15.2% |
| Stroke 543 cases | Too few cases | 10.6% | 11.9% |
| COPD 108 cases | Too few cases | 7.1% | 8.6% |
| Heart bypass surgery (CABG) 92 cases | Too few cases | 1.8% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1 likely 0.71 – 1.29 | 1 |
| After hip or knee replacement 42 cases | Too few cases | 3.7% | 4.1% |
| Deaths after a serious but treatable surgical complication 107 cases | No different | 134.38 per 1,000 likely 88.72 per 1,000 – 180.03 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 6,639 cases | No different | 0.53 per 1,000 likely 0 per 1,000 – 1.11 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 7,156 cases | No different | 0.15 per 1,000 likely 0 per 1,000 – 0.35 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 7,327 cases | No different | 0.21 per 1,000 likely 0.02 per 1,000 – 0.4 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,570 cases | No different | 1.45 per 1,000 likely 0.08 per 1,000 – 2.82 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 527 cases | No different | 1.62 per 1,000 likely 0.12 per 1,000 – 3.12 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 556 cases | No different | 9.53 per 1,000 likely 3.13 per 1,000 – 15.94 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,710 cases | No different | 4.86 per 1,000 likely 2.89 per 1,000 – 6.84 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 594 cases | No different | 5.09 per 1,000 likely 1.65 per 1,000 – 8.52 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 395 cases | No different | 1.82 per 1,000 likely 0.4 per 1,000 – 3.24 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,143 cases | No different | 1.28 per 1,000 likely 0.31 per 1,000 – 2.24 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.32 likely 0.18 – 0.52 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.55 likely 0.26 – 1.05 | 1 |
| Surgical site infections after colon surgery | No different | 1.34 likely 0.59 – 2.65 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0 | 1 |
| MRSA bloodstream infections | No different | 1.1 likely 0.62 – 1.8 | 1 |
| C. diff intestinal infections | Better | 0.39 likely 0.3 – 0.51 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 400 cases | Too few cases | 16% | 14.4% |
| Readmitted after heart failure 1,238 cases | Too few cases | 21.4% | 21.3% |
| Readmitted after pneumonia 700 cases | Too few cases | 17.2% | 17.3% |
| Readmitted after COPD 385 cases | Too few cases | 21.4% | 20% |
| Readmitted after heart bypass surgery 152 cases | Too few cases | 13% | 11% |
| Readmitted after hip or knee replacement 40 cases | Too few cases | 5.2% | 5.8% |
| Days back in hospital after a heart attack 139 cases | Too few cases | 39.8 days per 100 | — |
| Days back in hospital after heart failure 460 cases | Too few cases | 17 days per 100 | — |
| Days back in hospital after pneumonia 334 cases | Too few cases | 2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 292 cases | No different | 13 per 1,000 likely 9.8 per 1,000 – 17.3 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 311 cases | No different | 10.7 per 100 likely 8.4 per 100 – 13.7 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 311 cases | No different | 4.4 per 100 likely 3.1 per 100 – 6.2 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 304 cases | No different | 1.2 likely 0.9 – 1.5 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
463 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 40 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Emergency Medicine | 41 |
| Critical Care Medicine | 33 |
| Nurse Anesthetist, Certified Registered | 32 |
| Diagnostic Radiology | 25 |
| Pediatrics | 25 |
| Anatomic Pathology & Clinical Pathology | 23 |
| Pharmacist | 21 |
| Acute Care | 17 |
| Family | 15 |
| Nurse Practitioner | 14 |
| Pediatric Critical Care Medicine | 14 |
| Anesthesiology | 13 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.1M
- 2020 $2M
- 2021 $1.8M
- 2022 $3M
- 2023 $1.9M
- 2024 $2M
- 2025 $3.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $531,212 | 11 |
| Space rental and facility fees | $121,205 | 38 |
| Speaking, teaching and other services | $21,680 | 10 |
| Grants | $12,000 | 2 |
| Education | $6,000 | 2 |
| Debt forgiveness | $469 | 3 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Pfizer INC. | $544,751 | 27 |
| Cytovale, Inc. | $431,571 | 1 |
| Abbvie INC. | $345,587 | 34 |
| Eli Lilly and Company | $245,751 | 4 |
| Janssen Research & Development, LLC | $198,699 | 30 |
| AstraZeneca Pharmaceuticals LP | $190,206 | 7 |
| Genentech, Inc. | $177,813 | 35 |
| MicroVention, Inc. | $140,301 | 86 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS PFIZER INC. | $517,700 |
| EMBER-4: A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ADJUVANT IMLUNESTRANT VS STANDARD ADJUVANT ENDOCRINE THERAPY IN PATIENTS WHO HAVE PREVIOUSLY RECE… Eli Lilly and Company · NCT05514054 | $245,751 |
| A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Ref… ABBVIE INC. · NCT05451810 | $214,137 |
| a phase 3 multi center,open label,sponsor blinded,randomized study of azd0901 monotherapy compared with investigator s choice of therapy in second or… AstraZeneca Pharmaceuticals LP | $105,641 |
| A Study of TAR200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle invasive Bladder Cancer MIBC of the … Janssen Research & Development, LLC | $94,816 |
| Ph3 study of Pola R CHP Glofit vs PolaR CHP in 1L DLBCL Genentech, Inc. | $92,765 |
| M23-362 - A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relap… ABBVIE INC. | $79,632 |
| a randomised,open label,phase III study of saruparib AZD5305 plus camizestrant compared with physicians choice CDK4 6 inhibitor plus endocrine therap… AstraZeneca Pharmaceuticals LP | $72,781 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Memorial Regional Hospital
Is Memorial Regional Hospital a good hospital?
Memorial Regional Hospital has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 4. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Memorial Regional Hospital?
72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 3,584 completed HCAHPS surveys.
How long is the wait in the Memorial Regional Hospital emergency room?
Emergency patients spend a median of 2 h 37 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Memorial Regional Hospital receive money from drug and device companies?
Drug and device makers reported $3.1M in payments to Memorial Regional Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.